Bacainn was founded in 2017 in Concord, MA and has a discovery team based at University of Massachusetts Medical School in Worcester, MA.
Bacainn is funded by Morningside Ventures and operated by Morningside BioPharma Advisory. Bacainn’s novel insights into immune cell biology are directing the discovery and development of rationally-targeted therapies.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.